Ted Wun

Southern California Clinical and Translational Science Institute — United States

Medicine · Health Sciences

43h-index6.3kcitations152works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemoglobinopathies and Related Disorders(54), Venous Thromboembolism Diagnosis and Management(30), Iron Metabolism and Disorders(20), Acute Lymphoblastic Leukemia research(17), Childhood Cancer Survivors' Quality of Life(17)

Publications152 total

Low bone mineral density and pain impact in adults with sickle cell disease
Blood Advances·2025Open Access
ASH sickle cell disease CPKD guidelines report
Blood Advances·2025Open Access
Peripheral Neuropathy Incidence in Children, and Adolescents and Young Adults With Cancer and Medicaid Insurance in California
JCO Oncology Practice·2025· 1 citedOpen Access
Rates of strokes in Californians with sickle cell disease in the post-STOP era
Blood·2024· 8 citedOpen Access
The clinical spectrum of <scp>HbSC</scp> sickle cell disease‐not a benign condition
British Journal of Haematology·2024· 15 citedOpen Access
Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry
Blood Advances·2024Open Access
Association of IVCF use with mortality and intracranial hemorrhage in patients with selected cancers and brain metastasis
Blood Vessels Thrombosis & Hemostasis·2024Open Access
Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study
British Journal of Cancer·2024· 7 citedOpen Access
Utilization of Autologous Hematopoietic Cell Transplantation Over Time in Multiple Myeloma: A Population-Based Study
Clinical Lymphoma Myeloma & Leukemia·2023· 6 citedOpen Access
Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018
Transplantation and Cellular Therapy·2023· 3 citedOpen Access
Age-Related Differences in Utilization of Allogeneic HCT for Acute Myeloid Leukemia in California: Results of a Population-Based, Novel Linked Dataset
Blood·2023
Management of Malignancies in Patients with Sickle Cell Disease
Blood·2023Open Access
Association between Low Bone Mineral Density and Pain in a Prospective Cohort of Adults with Sickle Cell Disease: Preliminary Results from the SCD Bone Pain Study
Blood·2023Open Access
Predicting venous thromboembolism (VTE) risk in cancer patients using machine learning
Health care science·2023· 5 citedOpen Access
Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease
Journal of Clinical Oncology·2023· 43 citedOpen Access
Pregnancy outcomes in women with sickle cell disease in California
American Journal of Hematology·2023· 34 citedOpen Access
Subsequent Solid Neoplasms Following Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies: Comparing Center for International Blood and Marrow Transplant Research (CIBMTR) and California Cancer Registry (CCR) Data
Blood·2022
A Review of Sickle Cell Disease—Reply
JAMA·2022· 3 cited
Incidence of Ischemic Stroke Has Increased in Californians with Sickle Cell Disease in the Post-STOP Era
Blood·2022· 1 cited
Linking the Center for International Blood and Marrow Transplant Research Registry to the California Cancer Registry and California Hospital Patient Discharge Data
Transplantation and Cellular Therapy·2022· 6 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Ann Brunson(14), Theresa H.M. Keegan(11), Richard H. White(8), Anjlee Mahajan(7), Teresa Paglieroni(5), Alok A. Khorana(4), Helen K. Chew(4), Howard A. Liebman(3), Nicole M. Kuderer(3), Gary H. Lyman(3), Lakshmanan Krishnamurti(3), John L. Magnani(3), Anthony Cheung(3), Oyebimpe Adesina(3), Julie Kanter(3), Qian Li(3), Gerald A. Soff(2), Ajay K. Kakkar(2), Saroj Vadhan‐Raj(2), Hanno Riess(2)